Hepatic Tumors: Region-of-Interest versus Volumetric Analysis for Quantification of Attenuation at CT

被引:29
作者
Chalian, Hamid [1 ]
Tochetto, Sandra M. [1 ]
Toere, Hueseyin G. [1 ]
Rezai, Pedram [1 ]
Yaghmai, Vahid [1 ]
机构
[1] Northwestern Univ, Dept Radiol, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
MULTIDETECTOR ROW CT; LIVER METASTASES; HEPATOCELLULAR-CARCINOMA; COMPUTED-TOMOGRAPHY; COLORECTAL-CANCER; IMATINIB MESYLATE; THORACIC CT; HELICAL CT; FDG PET; PART;
D O I
10.1148/radiol.11110106
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To evaluate the reproducibility of liver tumor attenuation measurement performed by using the routinely used manual region-of-interest (ROI) method and that of measurement performed by using a semiautomated volumetric approach at computed tomography (CT). Materials and Methods: This HIPAA-compliant retrospective study had institutional review board approval. The requirement for patient informed consent was waived. Attenuation of colon cancer liver metastases in 208 patients was measured on portal venous phase multidetector CT images by using a single ROI, the average measurement in three ROIs on a single section, and with semiautomated segmentation of the entire tumor volume (volumetric attenuation) to evaluate intermethod agreement. Intraobserver and interobserver reproducibility were evaluated in the first 70 patients. Measurements were repeated after 30 days to assess intraobserver reproducibility. Differences between methods were tested by using repeated-measures analysis of variance. Intermethod, intraobserver, and interobserver agreements were tested by using Bland-Altman analysis and the Lin concordance correlation coefficient (rho(c)). P < .05 was considered to indicate a significant difference. Results: A total of 208 pathologically proven colon cancer hepatic metastases larger than 20 mm in diameter in 100 women and 108 men (mean age, 61.6 years +/- 11.6 [standard deviation]; range, 28-87 years) were evaluated. Attenuation was significantly different between the three methods of measurement (P < .001 for all). Volumetric measurements had better intraobserver agreement (precision = 3.3%, rho(c) = 0.996, P < .001) than single-ROI measurements (precision = 12.0%, rho(c) = 0.947, P < .001) and measurements averaged over three ROIs (precision = 9.3%, rho(c) = 0.965, P < .001). Volumetric measurements also had better interobserver agreement (precision = 3.6%, rho(c) = 0.993, P < .001) than single-ROI measurements (precision = 11.3%, rho(c) = 0.957, P < .001) and the average measurement in three ROIs (precision = 8.5%, rho(c) = 0.976, P < .001). Conclusion: Measurements of hepatic tumor attenuation at multidetector CT are reproducible. An approach based on the evaluation of whole-lesion attenuation demonstrated better reproducibility than ROI measurements.
引用
收藏
页码:853 / 861
页数:9
相关论文
共 35 条
  • [1] Informatics in radiology (infoRAD) -: New tools for computer assistance in thoracic CT -: Part 2.: Therapy monitoring of pulmonary metastases
    Bornemann, L
    Kuhnigk, JM
    Dicken, V
    Zidowitz, S
    Kuemmerlen, B
    Krass, S
    Peitgen, HO
    Wein, BB
    Schubert, H
    Shin, HO
    Wormanns, D
    [J]. RADIOGRAPHICS, 2005, 25 (03) : 841 - 848
  • [2] OncoTREAT: a software assistant for cancer therapy monitoring
    Bornemann, Lars
    Dicken, Volker
    Kuhnigk, Jan-Martin
    Wormanns, Dag
    Shin, Hoen-Oh
    Bauknecht, Hans-Christian
    Diehl, Volker
    Fabel, Michael
    Meier, Stefan
    Kress, Oliver
    Krass, Stefan
    Peitgen, Heinz-Otto
    [J]. INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY, 2007, 1 (05) : 231 - 242
  • [3] Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference
    Bruix, J
    Sherman, M
    Llovet, JM
    Beaugrand, M
    Lencioni, R
    Burroughs, AK
    Christensen, E
    Pagliaro, L
    Colombo, M
    Rodés, J
    [J]. JOURNAL OF HEPATOLOGY, 2001, 35 (03) : 421 - 430
  • [4] Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis
    Buyse, M
    Thirion, P
    Carlson, RW
    Burzykowski, T
    Molenberghs, G
    Piedbois, P
    [J]. LANCET, 2000, 356 (9227) : 373 - 378
  • [5] CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: A quantitative analysis correlated with FDG PET findings
    Choi, H
    Charnsangavej, C
    Faria, SD
    Tamm, EP
    Benjamin, RS
    Johnson, MM
    Macapinlac, HA
    Podoloff, DA
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2004, 183 (06) : 1619 - 1628
  • [6] Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: Proposal of new computed tomography response criteria
    Choi, Haesun
    Charnsangavej, Chuslip
    Faria, Silvana C.
    Macapinlac, Homer A.
    Burgess, Michael A.
    Patel, Shreyaskumar R.
    Chen, Lei L.
    Podoloff, Donald A.
    Benjamin, Robert S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) : 1753 - 1759
  • [7] Tumor angiogenesis:: pathophysiology and implications for contrast-enhanced MRI and CT assessment
    Cuenod, CA
    Fournier, L
    Balvay, D
    Guinebretière, JM
    [J]. ABDOMINAL IMAGING, 2006, 31 (02): : 188 - 193
  • [8] Pancreatic Endocrine Tumors: Tumor Blood Flow Assessed with Perfusion CT Reflects Angiogenesis and Correlates with Prognostic Factors
    d'Assignies, Gaspard
    Couvelard, Anne
    Bahrami, Stephane
    Vullierme, Marie-Pierre
    Hammel, Pascal
    Hentic, Olivia
    Sauvanet, Alain
    Bedossa, Pierre
    Ruszniewski, Philippe
    Vilgrain, Valerie
    [J]. RADIOLOGY, 2009, 250 (02) : 407 - 416
  • [9] Quantification of Urinary Stone Volume: Attenuation Threshold-based CT Method-A Technical Note
    Demehri, Shadpour
    Kalra, Mannudeep K.
    Rybicki, Frank J.
    Steigner, Michael L.
    Lang, Matthew J.
    Houseman, E. Andres
    Curhan, Gary C.
    Silverman, Stuart G.
    [J]. RADIOLOGY, 2011, 258 (03) : 915 - 922
  • [10] New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
    Eisenhauer, E. A.
    Therasse, P.
    Bogaerts, J.
    Schwartz, L. H.
    Sargent, D.
    Ford, R.
    Dancey, J.
    Arbuck, S.
    Gwyther, S.
    Mooney, M.
    Rubinstein, L.
    Shankar, L.
    Dodd, L.
    Kaplan, R.
    Lacombe, D.
    Verweij, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) : 228 - 247